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Genetic targeting of Purkinje fibres 
by Sema3a-CreERT2
Yan Li  1,2, Xueying Tian  1,2, Huan Zhao1,2, Lingjuan He  1,2, Shaohua Zhang1,2,  
Xiuzhen Huang  1,2, Hui Zhang  1,2, Lucile Miquerol3 & Bin Zhou1,2,4,5
The maintenance of the heart rhythm and the conduction of excitatory signals require changing 
excitatory signals via electrical activity and coordination by communication between working and 
conductive cardiomyocytes. Understanding how the ventricular conduction system is established 
provides novel insights into the pathophysiological progress of cardiac arrhythmias. However, the 
major hurdle in this field is the lack of a specific genetic tool that targets the Purkinje fibres of the 
ventricular conduction system and no other types of cardiomyocytes or coronary vessels. Here, we 
generated a Sema3a-CreERT2 knock-in mouse line to test its specificity for genetically labelled Purkinje 
fibres. We found that Sema3a was expressed in the subendocardial layer of the trabecular myocardium 
in the embryonic heart and was restricted to the Purkinje fibres in the adult heart. A fate mapping study 
based on the Sema3a-CreERT2 line revealed that the Sema3a+ cardiomyocytes were restricted to the 
fate of Purkinje fibres in the perinatal but not the embryonic stage. Collectively, our study provides 
a new genetic tool, i.e., Sema3a-CreERT2, for studying the molecular mechanisms that regulate the 
function of Purkinje fibres.
The cardiac conduction system controls cardiac contraction by regulating the propagation of the electrical activ-
ity through the heart. Defects in the cardiac conduction system may lead to cardiac arrhythmias. Cardiac con-
traction begins in the right atrium, where it is initiated by the sinoatrial node (SA node). Then, the electrical 
activity is delayed at the atrioventricular node (AV node) and subsequently rapidly propagated throughout the 
ventricular wall through the fast-conducting atrioventricular bundle (the bundle of His and the bundle branches), 
which is localized at the crest of interventricular septum, and the peripheral left and right ventricular Purkinje 
fibres that are localized to the subendocardial surface of the myocardial wall1. The Purkinje fibres ensure the 
rapid propagation of electric pulses that permit the efficient and effective pumping of blood from the ventricles. 
Understanding the molecular mechanisms that regulate Purkinje fibre development, formation, maintenance and 
proper function will provide insights into the pathophysiological process of cardiac arrhythmias. A recent study 
demonstrated that Hcn4-CreERT2 labels the conduction system including the sinoatrial node, a subset of the atri-
oventricular node, the bundle of His, the bundle branches and the Purkinje fibres2,3. Additionally, Hcn4-CreERT2 
also labels a subset of endothelial cells in the developing heart2,3. Cntn2-Cre is another genetic tool for the cardiac 
conduction system that specifically targets the SA node, AV node, left and right bundle branches and the Purkinje 
fibres4. Previous research has revealed that connexin 40 (Cx40) is largely restricted to the ventricular conduction 
system (VCS), and it is also expressed in atrial cardiomyocytes and coronary arterial endothelial cells5,6. The 
genetic tool Cx40-CreERT2 targets both atrial and VCS cardiomyocytes, as well as coronary endothelial cells1,7. 
Therefore, the generation of a new tool that specifically targets the Purkinje fibres without targeting other cells 
may be valuable for specifically studying the function of Purkinje fibres.
Sema3a is a member of the semaphorin family that is conserved from invertebrates to vertebrates. Recent 
studies indicate that Sema3a has an important function in the development of the nervous system8,9. Sema3a 
could be a chemorepellent that inhibits the outgrowth of axons, especially peripheral axons, to maintain a nor-
mal neuronal pattern10. The overexpression of Sema3a can lead to nerve diseases, such as schizophrenia, but 
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defects in Sema3a result in abnormal neuronal innervation11,12. Moreover, Sema3a also plays physiological roles 
in immunoregulation13 and cancer development14. A recent study indicates that Sema3a can maintain a nor-
mal heart rhythm by mediating the patterning of the sympathetic innervation15. Interestingly, the expression of 
Sema3a is detected in the Purkinje fibres and a subset of trabecular cardiomyocytes, but to our knowledge, line-
age tracing results regarding Sema3a in the cardiac conduction system have not yet been reported. In our study, 
we delineated the expression patterns of Sema3a in the developing and adult heart. The genetic lineage tracing 
analysis with Sema3a-CreERT2 revealed that Sema3a specifically labels Purkinje fibres in the adult heart, and the 
fate of these specialized cardiomyocytes is actually determined in the perinatal stage. These results expand our 
knowledge about the development of the VCS and provide a new genetic mouse tool for the study of Purkinje 
fibre function.
Results
Generation and characterization of the Sema3a-CreERT2 mouse line. We generated a Sema3a-
CreERT2 knock-in mouse line by homologous recombination using a conventional ES cell-based targeting 
strategy. These Sema3a-CreERT2 mice expressed the tamoxifen-inducible CreERT2 recombinase (CreERT2) 
under the endogenous transcriptional control of the Sema3a gene (Fig. 1a). DNA from the tails of heterozy-
gous mice (Sema3a-CreERT2) and wild-type littermates (Sema3a+/+) was extracted for polymerase chain 
reaction (PCR) experiments. The Sema3a-CreERT2 mice had two bands: one band corresponded to the 
mutant knock-in allele, and the other band corresponded to the wild-type allele (Fig. 1b). Un-cropped PCR 
gel pictures are presented in Supplementary Fig. 1. Homozygous mutant mice were not obtained in our study 
due to the high postnatal mortality of Sema3a null mutations11. To detect the function of these heterozygous 
Figure 1. Generation and characterization of the Sema3a-CreERT2 knock-in mouse line. (a) Schematic 
diagrams showing the wild-type (wt) allele and the CreERT2 knock-in Sema3a allele. The arrows indicate 
the primers that were designed for genotyping. (b) Genotyping of the Sema3a-CreERT2 allele by PCR. The 
band size is presented on the left. M, molecular marker. (c) Immunostaining for oestrogen receptor (ESR) as a 
surrogate for Sema3a on E12.5, E14.5 and E19.5 Sema3a-CreERT2 heart sections. The arrows indicate Sema3a+ 
cardiomyocytes. Scale bars, 100 µm.
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mice, we tested the ejection fraction and the fractional shortening of 8-week-old mice and found no signif-
icant difference between the Sema3a-CreERT2 and the Sema3a+/+ littermate control mice (Supplementary 
Fig. 2a,b). ECG and echocardiography revealed that the Sema3a-CreERT2 mice exhibited normal heart func-
tion at the age of 8 weeks (Supplementary Fig. 2c). To test whether the knock-in allele was expressed as 
expected, we first used oestrogen receptor (ESR) antibody staining as a surrogate for Sema3a expression in 
embryonic lung and bone tissue. ESR/Sema3a was highly expressed in both organs (Supplementary Fig. 3), 
which is consistent with a previous study16. Then, we co-stained for ESR and TNNI3 in E12.5, E14.5 and E19.5 
embryonic heart sections. The immunostaining results revealed that ESR/Sema3a expression was largely 
restricted to the trabecular myocardium, but minimal staining was detected in the compact layer in the E12.5 
and E14.5 embryonic hearts (Fig. 1c). At E19.5, ESR/Sema3a was expressed in a subset of subendocardial 
trabecular cardiomyocytes that were located along the side of the ventricular chamber (Fig. 1c). ESR/Sema3a 
was not detected in the cardiomyocytes or the coronary arteries of the compact myocardium (Fig. 1c), which 
is consistent with a previous study of Sema3a expression15. Taken together, these data demonstrated the suc-
cessful generation of the Sema3a-CreERT2 mouse line.
Sema3a-CreERT2 labels Purkinje fibres in the adult mouse heart. According to the ESR staining 
analysis of the Sema3a-CreERT2 mice, Sema3a was primarily expressed in the trabecular cardiomyocytes and not 
in the compact layer. Since Purkinje fibres are restricted in the innermost layer of the ventricular myocardial wall5, 
we next determined whether Sema3a-CreERT2 could specifically target these specialized cardiomyocytes in the 
adult mouse heart. We crossed Sema3a-CreERT2 mice with R26-tdTomato17 mice to generate Sema3a-CreERT2; 
R26-tdTomato double-positive mice (Fig. 2a). CreERT2 is retained in the cytoplasm, and, only in the presence of 
tamoxifen18, CreERT2 translocates into the nucleus for Cre-loxP recombination (Fig. 2b), which leads to a per-
manent tdTomato expression in the Sema3a+ cells and their descendants19. We treated 8-12-week-old mice with 
tamoxifen and collected the hearts 48 hours after the tamoxifen treatment. We found that very sparse RFP+ cells 
were detected among the atrial cardiomyocytes (Fig. 2c,d). To determine whether Sema3a was expressed in the 
SA node and the AV node, we co-stained for HCN4 and RFP and found that Sema3a was not expressed in the SA 
node and was sparsely expressed in the AV node (Fig. 2e,f). With the purpose of detecting whether Sema3a was 
expressed in the stellate ganglia or cardiac nerves, we co-stained for RFP and tyrosine hydroxylase (TH, which 
is a marker of the stellate ganglia) and co-stained for RFP and Tuj1 (a marker of cardiac nerves) and found that 
Sema3a was not expressed in the stellate ganglia or in the cardiac nerves (Supplementary Fig. 4a,b). Because Cx40 
has been reported to mark the VCS, we generated Sema3a CreERT2; R26-tdTomato; Cx40 GFP5 triple-positive 
mice to test for the expression of Sema3a in the Purkinje fibres. By immunostaining heart sections for RFP and 
GFP, we found that RFP was co-localized with GFP+ cells in the subendocardial layer of the ventricular wall, 
whereas RFP was not detected in the GFP+ coronary arteries in the compact myocardium (Fig. 2g). We next dis-
sected the ventricles for whole-mount fluorescence views of the inside of the Sema3a-CreERT2; R26-tdTomato; 
Cx40-GFP mouse hearts (Fig. 2h and Supplementary Fig. 5). Cx40 exhibited gross expression in the atrium, 
whereas Sema3a was hardly detected. Cx40 was also expressed in the bundle of His (HB), in the left and right 
bundle branches, and in the Purkinje fibres, which is consistent with a previous report5. Compared with Cx40 
(GFP signal), Sema3a (RFP signal) was largely restricted to the Purkinje fibres and was not detected in the bundle 
of His or the bundle branches (Fig. 2h,i). Z-stack confocal microscopy confirmed the expression of Sema3a (RFP 
signal) in the Cx40+ Purkinje fibres that reside in the subendocardial location of the ventricular myocardium 
(Fig. 2j). The same pattern of Sema3a expression was observed in the right ventricle (Supplementary Fig. 5). These 
data demonstrated that Sema3a-CreERT2 specifically targeted the ventricular Purkinje fibres in the adult mouse 
heart.
Fate-mapping analysis of Purkinje fibre development with Sema3a-CreERT2. Since Sema3a was 
expressed in a broader domain during the embryonic stages than in the adults, we asked when Sema3a+ car-
diomyocytes were specialized to the fate of Purkinje fibres in the developing hearts. We injected tamoxifen 
at E12.5, E14.5 or E18.5 into Sema3a-CreERT2; R26-tdTomato; Cx40-GFP triple-positive mice and collected 
the hearts at P7 or P21 for analysis. The lineage tracing data revealed that the Sema3a+ cells at E12.5 gave rise 
to both the Cx40+ Purkinje fibres (minority) and Cx40− working cardiomyocytes (majority) at P7 and P21 
(Fig. 3a,b). The Sema3a+ cells at E14.5 were more restricted to the subendocardial layer of the ventricular 
myocardium and gave rise to the Cx40+ Purkinje fibres and Cx40− working cardiomyocytes at P7 and P21 
(Fig. 3c,d). The Sema3a+ cells at E18.5 gave rise to almost all of the Cx40+ Purkinje fibres in the subendocar-
dial surface of the ventricular myocardium at P7 and P21 and gave rise to few if any Cx40− working cardi-
omyocytes (Fig. 3e,f). These data demonstrated that the fate of Sema3a+ cardiomyocytes was specialized to 
Purkinje fibres in the perinatal stage (e.g., E18.5) when their cell fate was restricted to the ventricular conduc-
tion system (Fig. 3g).
Quantification of the Sema3a+ cardiomyocytes. Finally, we quantified the percentage of cardi-
omyocytes that were labelled with Sema3a-CreERT2; R26-tdTomato in the adult mouse hearts. Tamoxifen 
was injected into the adult mice, and the hearts were collected for analysis 48 hours after the tamoxifen treat-
ment. Immunostaining of the Sema3a-CreERT2; R26-tdTomato hearts for RFP and TNNI3 revealed RFP+ 
cardiomyocytes in the subendocardial surface of the ventricular myocardium (Fig. 4a). Quantification of the 
percentage of RFP+ cardiomyocytes in the heart sections revealed that 1.02 ± 0.13% of the cardiomyocytes 
were labelled with Sema3a-CreERT2, and there were almost no cardiomyocytes that were labelled without 
the tamoxifen treatment (Fig. 4c). We also isolated cardiomyocytes and placed them in dishes for quanti-
fication (Fig. 4b). We found that 1.10 ± 0.18% of the cardiomyocytes were RFP+ in the tamoxifen-treated 
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mouse hearts, and very few RFP+ cardiomyocytes were present in the mice without the tamoxifen treatment 
(Fig. 4d). These findings were consistent with the quantification obtained following immunostaining of the 
heart sections (Fig. 4c).
Discussion
In this study, we generated a new genetic tool, i.e., Sema3a-CreERT2, which specifically targets Purkinje fibres in 
the adult mouse heart. In contrast, Hcn4-CreERT2 targets the sinoatrial node, atrioventricular node, the bundle 
of His, the bundle branches and the Purkinje fibres, and Cntn2-Cre is detected in the SA node, AV node, and 
Figure 2. The adult expression map of Sema3a in the heart. (a) Schematic showing the crossing of the mice to 
generate the Sema3a-CreERT2; R26-tdTomato mice. (b) Genetic labelling of the Sema3a+ cells via tamoxifen 
administration. (c) Whole-mount fluorescence and bright-field views of a Sema3a-CreERT2; R26-tdTomato 
mouse heart. (d) Immunostaining for RFP and TNNI3 on a Sema3a-CreERT2; R26-tdTomato heart section 
showing the rarity of RFP+ cells in the atrium. LA, left atrium. (e) No Sema3a+ cells were detected in the 
SA node. (f) The expression of Sema3a in the AV node. (g) Immunostaining for RFP, GFP and TNNI3 in a 
Sema3a-CreERT2; R26-tdTomato; Cx40-GFP mouse heart section showing that the CX40+ coronary artery 
(arrowhead) was negative for RFP. (h) Whole-mount fluorescence view of a Sema3a-CreERT2; R26-tdTomato; 
Cx40-GFP mouse heart. LBB, left bundle branch; LPF, left Purkinje fibre; IVS, interventricular septum; LVW, 
left ventricular free wall. The dotted line indicates the limits between the IVS and the LVW. (i) Immunostaining 
for RFP and GFP on heart sections of a Sema3a-CreERT2; R26-tdTomato; Cx40-GFP mouse. Sema3a was not 
detected in the LBB or RBB, which were positive for Cx40-GFP. (j) Z-stack confocal image showing that Sema3a 
was expressed in the Purkinje fibres. XZ and YZ indicate the signals from the dotted lines on the Z-stack images 
in (j). Scale bars, 1 mm in (c) 500 µm in (e,g,h) and 100 µm in (d,f,i) and (j). Each image is representative of 5 
individual samples.
www.nature.com/scientificreports/
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His-Purkinje system4. In contrast to the Cx40-CreERT2 tool, Sema3a-CreERT2 does not label coronary arte-
rial endothelial cells or atrial cardiomyocytes. The fate mapping study also revealed that the Sema3a+ cells were 
trabecular cardiomyocytes in the early embryonic stage, and during the perinatal period, the Sema3a+ cardio-
myocytes specialized into the Purkinje fibre fate. Since our CreERT2 is inducible, and its efficiency is not 100%, 
the Sema3a-CreERT2 labelled most, but not all, of the Cx40-GFP cells. In the heart, we detected RFP+GFP+ 
labelled cells and RFP−GFP+ unlabelled cells in the P7 and P21 hearts. No significant dilution of RFP labelling 
efficiency was observed from P7 to P21. It might be possible, although unlikely, that a few Cx40-GFP+ cells could 
be recruited from myocytes at a later stage. Furthermore, tamoxifen treatment lasts 1–2 days for the labelling of 
cells; we, therefore, cannot formally exclude the possibility that a small number of CreERT2+ cells were labelled 
Figure 3. Specialization of Sema3a+ cardiomyocytes into the conduction system in the developing heart. 
(a–f) Z-stack images of RFP and GFP immunostaining on Sema3a-CreERT2; R26-tdTomato; Cx40-GFP heart 
sections. Tamoxifen was administered at E12.5 (a,b), E14.5 (c,d) and E18.5 (e,f). The hearts were collected at 
P7 and P21 for each group. YZ indicates signals from the dotted lines on the Z-stack images. Scale bars, 50 µm. 
Each image is representative of 5 individual samples. (g) Schematic figure showing Sema3a+ cells (red) and 
Cx40+ cells (green) in the developing and adult heart.
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at a later stage due to incomplete clearance of the tamoxifen from the body. We believe this possibility is unlikely 
because the majority of tamoxifen is cleared after 1–2 days, and the labelling of the CreERT2+ cells afterwards 
should be minimal. Additionally, the expression domain of CreERT2 (Sema3a) in the myocardium decreases 
rather than increases during embryonic development (e.g., compare E12.5, E14.5 and E19.5 in Fig. 1c). A broader 
Cre-loxP recombination domain is, therefore, unlikely even if there is residual tamoxifen remaining after 1–2 
days. In conclusion, Sema3a-CreERT2 is the first genetic mouse tool for the specific targeting of Purkinje fibres 
and provides a means for the in vivo functional study of Purkinje fibres during ventricular conduction system 
formation and cardiac arrhythmias.
Materials and Methods
Animals. All mouse lines used in this study were handled according to the guidelines of the Institutional 
Animal Care and Use Committee (IACUC) at the Institute for Nutritional Sciences, Shanghai Institute of 
Biochemistry and Cell Biology, Shanghai Institutes for Biological Science, Chinese Academy of Science 
(approved protocol number 2015-AN-8). We generated the Sema3a-CreERT2 knock-in mouse line by knock-
ing a cDNA encoding Cre recombinase fused with a mutant form of the oestrogen receptor hormone-binding 
domain into the Sema3a locus20. Briefly, a 129-bp mouse BAC clone containing the complete mouse Sema3a 
gene was obtained from the Sanger Institute (UK). The targeting vector was generated using the following 
Figure 4. Quantification of the numbers of Sema3a+ cardiomyocytes in the adult heart. (a) Immunostaining 
for RFP and TNNI3 on adult heart sections. IVS, interventricular septum; RVW, right ventricular wall. Scale 
bars: white, 100 µm; yellow, 50 µm. (b) Image of isolated cardiomyocytes from the adult Sema3a CreERT2; R26-
tdtomato heart showed Sema3a+ cardiomyocytes. (c) Quantification of the percentages of RFP+ cardiomyocytes 
in the heart sections. (d) Quantification of the percentages of RFP+ cells from among isolated cardiomyocytes. 
Each image is representative of 5 individual samples.
www.nature.com/scientificreports/
7SCIENTIfIC REPORTs |  (2018) 8:2382  | DOI:10.1038/s41598-018-20829-9
cassettes: CreERT2 cDNA, SV40 polyA sequence, and Frt site-flanked PGK-EM7-Neo resistant gene. The neo 
cassettes were detected by PCR (Fig. 1b). All mice were maintained on a C129/C57BL6/J mixed background. 
Sema3a-CreERT2 mice were crossed with R26-tdTomato (Ai9)17 and Cx40-GFP5 mice to generate Sema3a-
CreERT2; R26-tdTomato and Sema3a-CreERT2; R26-tdTomato; Cx40-GFP mouse lines for genetic lineage trac-
ing of the Sema3a cells. Tamoxifen (Sigma, T5648) was dissolved in corn oil and introduced by gavage at the 
indicated times (0.1–0.15 mg/g mouse body weight). To determine the exact timing of the embryonic stages, 
we checked for a vaginal plug and recorded the result as embryonic day 0.5, then we injected tamoxifen at 
embryonic days 12.5, 14.5 and 18.5. The day of the mouse birthday was postnatal day 0, and the hearts were 
collected at postnatal days 7 and 21. To assess the leakiness of the inducible Cre in the absence of tamoxifen, 
we introduced corn oil by gavage to the Sema3a-CreERT2; R26-tdTomato mice in parallel. We designed PCR 
primers that spanned the genomic DNA and inserted cassette as follows: F1: CCTTTCATTCT GCTTCCTCGG, 
R1: TGCGAACCTCATCACTCGTTG (to test for the correct target allele of 533 bp); and F1: CCTTTC 
ATTCTGCTTCCTCGG, R2: GCTTTGATGGTTAG CGTTGGG (to test for the wild-type allele of 658 bp); and 
F2: CGACCACCAAGCGAAAC ATC, R3: AAAGACAGGCAATCCCAGTGAAC (to test for the Neo allele of 
790 bp). All mice were bred on a C129/C57BL6/J mixed background. We thank Shanghai Biomodel Organism 
Co., Ltd. for the mouse generation.
Immunostaining. Immunostaining was performed according to previous protocols21. Briefly, we collected 
mouse hearts or other organs and washed them in cold PBS several times. Then, the heart tissue was fixed in 4% 
PFA (Sigma), and the fixation time depended on the size of the organ. In general, the embryonic hearts were 
fixed for approximately 30 minutes, and the adult hearts were fixed for approximately 1 hour. After fixation, the 
hearts were dehydrated in 30% sucrose at 4 °C until the tissue was fully penetrated. After soaking the hearts 
at an optimal cutting temperature (OCT, Sakura) for approximately 1 hour at 4 °C, the tissues were embedded 
in blocks and frozen in a −80 °C fridge. For the section orientation, the hearts were sectioned in the coronal 
plane (four chamber orientation). We focused on the trabecular muscle in the embryonic heart and the SA node, 
AV node, the bundle of His, the bundle branches and the Purkinje fibres in the adult hearts. Cyrosections of 
8–10 µm thickness were collected on slides. The tissues were blocked in blocking solution (5% normal donkey 
serum in PBS with 0.1% Triton X-100) for 30 min at room temperature and subsequently incubated in the first 
antibodies overnight at 4 °C. After fully washing out the primary antibodies, the tissues were then developed 
with Alexa fluorescent antibodies (Invitrogen). For weak signals, we used HRP or biotin-conjugated antibodies 
(Jackson Immunoresearch) with a tyramide signal amplification kit (PerkinElmer). Before mounting the slides, 
the tissues were counterstained with 4′6-diamidino-2-phenylindole (DAPI, Vector Laboratories). The primary 
antibodies and dilution ratios were as follows: RFP (Rockland, 600-401-379,1:500); ESR (Abcam, ab27595, pre-
diluted); GFP (Nacalai Tesque, 04404–84, 1:100); GFP (Abcam, ab6662, 1:200); TNNI3 (Abcam, ab56357, 1:100); 
Cx40 (Alpha Diagnostic, Cx40-A, 1:100); HCN4 (Abcam, ab32675, 1:100); tyrosine hydroxylase (TH, Millipore, 
AB152, 1:100); and Tuj1 (Covance, MMS-435P, 1:100). The images were acquired with a Zeiss confocal micro-
scope (LSM510), an Olympus confocal microscope (FV1000), and a Zeiss stereo-microscope (AXIO Zoom. V16). 
To produce the Z-stack confocal images, we scanned 3–4 consecutive XY images on the z-axis with an Olympus 
confocal microscope (FV1000). Then, the images were analysed with ImageJ (NIH) software. In the stack data, 
an orthogonal view was used to reveal the merged signals on the XZ and YZ axes. The merged signals and split 
channels are presented to delineate the signals at a one-cell resolution. Each IHC data is representative of 3–5 
individual samples.
Whole-mount heart imaging. The whole-mount images of the adult heart were collected with a Zeiss 
stereo-microscope (AXIO Zoom. V16). The hearts were collected from 8–12-week-old mice, and the blood was 
removed via stimulation with necropsy tools. Then, the heart tissues were washed in cold PBS several times until 
the solution became limpid. We fixed the hearts in 4% PFA (Sigma) for approximately 1 hour at 4 °C and then 
washed them with cold PBS 3 times for 5 minutes each time. We removed the atrium with surgical scissors and 
then split the left and right ventricle walls with a scalpel. To expose the Purkinje fibres, we fixed the hearts in aga-
rose dishes with needles. Then, the images were collected with a Zeiss stereo-microscope.
Dissociated adult cardiomyocytes. Cardiomyocytes were isolated from the adult hearts as described 
previously22. Briefly, we intraperitoneally injected Sema3a-CreERT2; R26-tdTomato mice with 200 µl of heparin 
(6.25 U/µl). Twenty minutes later, the mice were intraperitoneally anaesthetized with 10% chloral hydrate. The 
dissected heart was perfused with modified Tyrode’s solution (MTS) for 5 min at a rate of 1 ml/min. The heart 
was next perfused for approximately 20–30 minutes at 37 °C with an enzyme buffer containing 250 U/ml colla-
genase type 2 (Worthington, LS004176) and 0.3 U/ml Protease XIV (Sigma, P5147) to dissociate the heart tissues. 
Micro-dissecting forceps were used to mince the ventricles into small pieces for dissociation and filtering with 
a 100-µm strainer. The isolated cells were centrifuged at 20× g for 3 minutes at 4 °C to allow for the collection of 
most of the cardiomyocytes.
Cardiomyocyte quantification. Cardiomyocytes were isolated from Sema3a-CreERT2; R26-tdTomato 
mice hearts within 48 hours of the injection of tamoxifen. All cardiomyocytes were collected in cell culture dishes, 
and the RFP+ cardiomyocytes were quantified under a Zeiss stereo-microscope (AXIO Zoom. V16). The total 
number of RFP+ cells from 5 hearts was divided by the total number of cardiomyocytes examined to obtain the 
percentage of RFP+ cardiomyocytes.
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Statistical analysis. All data in this study were determined from 3–5 independent experiments and are 
presented as the mean values ± the s.e.m. All mice in this study were randomly assigned to the different experi-
mental groups.
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